Ultragenyx Pharmaceutical(DE:UP0)
€14.58-0.36 (-2.38%)
DE:UP0
Ultragenyx Pharmaceutical earnings date
€14.58
At close:-0.36 (-2.38%)
Ultragenyx Pharmaceutical (UP0) Q2 2024 Earnings Report
2 Followers
DE:UP0 Q2 2024 EPS Results
- Actual EPS
- -EUR 1.37
- Consensus EPS
- -EUR 1.50
- Beat/Miss
- Beat by +EUR 0.13
- One Year Ago EPS
- -EUR 2.03
DE:UP0 Q2 2024 Revenue Results
- Actual Revenue
- EUR 132.90M
- Expected Revenue
- EUR 111.36M
- Beat/Miss
- Beat by +EUR 21.54M
- YoY Revenue Growth
- +35.75%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- After Close
- Conference Call
- Thursday, August 1, 2024
DE:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:UP0 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 2.16- | -1.17 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.99-1.05 | -1.64 | 35.91% (+0.59) | |
| Aug 04, 2026 | 2026 (Q2) | -1.12-0.81 | -1.06 | 23.08% (+0.24) | |
| May 05, 2026 | 2026 (Q1) | -1.35-1.66 | -1.42 | -17.20% (-0.24) | |
| Feb 12, 2026 | 2025 (Q4) | -0.99-1.17 | -1.26 | 7.19% (+0.09) | |
| Nov 04, 2025 | 2025 (Q3) | -1.12-1.64 | -1.27 | -29.29% (-0.37) | |
| Aug 05, 2025 | 2025 (Q2) | -1.17-1.06 | -1.37 | 23.03% (+0.32) | |
| May 06, 2025 | 2025 (Q1) | -1.44-1.42 | -1.83 | 22.66% (+0.42) | |
| Feb 13, 2025 | 2024 (Q4) | -1.18-1.26 | -1.37 | 8.55% (+0.12) | |
| Nov 05, 2024 | 2024 (Q3) | -1.34-1.27 | -2.02 | 37.22% (+0.75) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
